Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

February 5, 2024

Study Completion Date

August 26, 2024

Conditions
Safety IssuesEffect of Drug
Interventions
DRUG

Enoxaparin sodium injection

Originator Enoxaparin with a trade name is Lovenox.

Trial Locations (3)

11420

RS Jantung dan Pembuluh Darah Harapan Kita, Jakarta, Jakarta

80113

RSUP Prof. Dr. I.G.N.G Ngoerah, Bali, Bali

Unknown

RSUP Dr.Sardjito, Yogyakarta, Yogyakarta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PT Bio Farma

INDUSTRY

NCT06114641 - Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients | Biotech Hunter | Biotech Hunter